Synopsis
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Vasa Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Lubricants & Glidants
Direct Compression
Disintegrants & Superdisintegrants
Thickeners and Stabilizers
Film Formers & Plasticizers
Granulation
Coating Systems & Additives
Taste Masking
Co-Processed Excipients
Parenteral
Chewable & Orodispersible Aids
Controlled & Modified Release
Emulsifying Agents
Topical
API Stability Enhancers
Soft Gelatin
Rheology Modifiers
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
88
PharmaCompass offers a list of Diphenoxylate Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diphenoxylate Hydrochloride manufacturer or Diphenoxylate Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diphenoxylate Hydrochloride manufacturer or Diphenoxylate Hydrochloride supplier.
PharmaCompass also assists you with knowing the Diphenoxylate Hydrochloride API Price utilized in the formulation of products. Diphenoxylate Hydrochloride API Price is not always fixed or binding as the Diphenoxylate Hydrochloride Price is obtained through a variety of data sources. The Diphenoxylate Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A LONOX-1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LONOX-1, including repackagers and relabelers. The FDA regulates LONOX-1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LONOX-1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of LONOX-1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A LONOX-1 supplier is an individual or a company that provides LONOX-1 active pharmaceutical ingredient (API) or LONOX-1 finished formulations upon request. The LONOX-1 suppliers may include LONOX-1 API manufacturers, exporters, distributors and traders.
click here to find a list of LONOX-1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A LONOX-1 DMF (Drug Master File) is a document detailing the whole manufacturing process of LONOX-1 active pharmaceutical ingredient (API) in detail. Different forms of LONOX-1 DMFs exist exist since differing nations have different regulations, such as LONOX-1 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A LONOX-1 DMF submitted to regulatory agencies in the US is known as a USDMF. LONOX-1 USDMF includes data on LONOX-1's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The LONOX-1 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of LONOX-1 suppliers with USDMF on PharmaCompass.
A LONOX-1 CEP of the European Pharmacopoeia monograph is often referred to as a LONOX-1 Certificate of Suitability (COS). The purpose of a LONOX-1 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of LONOX-1 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of LONOX-1 to their clients by showing that a LONOX-1 CEP has been issued for it. The manufacturer submits a LONOX-1 CEP (COS) as part of the market authorization procedure, and it takes on the role of a LONOX-1 CEP holder for the record. Additionally, the data presented in the LONOX-1 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the LONOX-1 DMF.
A LONOX-1 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. LONOX-1 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of LONOX-1 suppliers with CEP (COS) on PharmaCompass.
A LONOX-1 written confirmation (LONOX-1 WC) is an official document issued by a regulatory agency to a LONOX-1 manufacturer, verifying that the manufacturing facility of a LONOX-1 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting LONOX-1 APIs or LONOX-1 finished pharmaceutical products to another nation, regulatory agencies frequently require a LONOX-1 WC (written confirmation) as part of the regulatory process.
click here to find a list of LONOX-1 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing LONOX-1 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for LONOX-1 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture LONOX-1 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain LONOX-1 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a LONOX-1 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of LONOX-1 suppliers with NDC on PharmaCompass.
LONOX-1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LONOX-1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right LONOX-1 GMP manufacturer or LONOX-1 GMP API supplier for your needs.
A LONOX-1 CoA (Certificate of Analysis) is a formal document that attests to LONOX-1's compliance with LONOX-1 specifications and serves as a tool for batch-level quality control.
LONOX-1 CoA mostly includes findings from lab analyses of a specific batch. For each LONOX-1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LONOX-1 may be tested according to a variety of international standards, such as European Pharmacopoeia (LONOX-1 EP), LONOX-1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LONOX-1 USP).
